Skip to main content

Want a detailed portfolio tracker?

Clearside Biomedical, Inc. Common Stock (CLSD) P/E (2016 - 2026)

Clearside Biomedical, Inc. Common Stock (CLSD) P/E from Sep 30, 2016 to Jun 3, 2026. The TTM Clearside Biomedical, Inc. Common Stock (CLSD) P/E is -0.08. You can export chart.

P/E

Annual P/E change of Clearside Biomedical, Inc. Common Stock (CLSD)

YearP/EChange
2026-0.08N/A
2025-0.08-96.00%
2024-2.01+4.88%
2023-1.92-87.18%
2022-14.97-97.70%
2021-651.10+9329.19%
2020-6.91+103.52%
2019-3.39+761.26%
2018-0.39-89.00%
2017-3.58-88.97%
2016-32.48N/A

Comparison Clearside Biomedical, Inc. Common Stock (CLSD) P/E with competitors

Clearside Biomedical, Inc. Common Stock (CLSD) P/E is -0.08.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-102.11%
NBYStablecoin Development Corp0.10-227.02%
ENLVEnlivex Therapeutics Ltd0.15-286.63%
FGENFibroGen Inc0.24-398.25%
TRAWTraws Pharma Inc0.47-687.48%
FBIOFortress Biotech Inc0.71-977.24%
CHRSCoherus Biosciences Inc0.98-1315.34%
ORMPOramed Pharmaceuticals Inc1.47-1930.77%
AGENAgenus Inc2.05-2645.23%
VIVSVivoSim Labs Inc2.54-3250.73%
INVAInnoviva Inc3.19-4061.74%
CRMDCorMedix Inc3.65-4629.83%
ABEOAbeona Therapeutics Inc4.20-5324.79%
VXRTVaxart Inc4.26-5395.12%
CVACCureVac N.V.4.45-5623.75%
SRPTSarepta Therapeutics Inc4.62-5845.66%
GLPGGalapagos NV4.86-6137.17%
RIGLRigel Pharmaceuticals4.92-6212.59%
ZVRAZevra Therapeutics Inc4.97-6280.31%
ABUSArbutus Biopharma Corp5.69-7174.57%
CGENCompugen Ltd7.38-9274.72%
AUPHAurinia Pharmaceuticals Inc9.25-11595.18%
ACADAcadia Pharmaceuticals Inc9.59-12013.42%
OMEROmeros Corporation9.88-12380.47%
PLXProtalix BioTherapeutics Inc9.91-12412.40%
SPROSpero Therapeutics Inc10.73-13438.25%
ADMAAdma Biologics Inc11.33-14178.69%
SVASinovac Biotech Ltd11.44-14309.65%
TBPHTheravance Biopharma Inc11.78-14732.86%
HRMYHarmony Biosciences Holdings Inc12.18-15234.60%
TGTXTG Therapeutics Inc13.18-16475.91%
INCYIncyte Corp13.38-16727.65%
SABSSAB Biotherapeutics Inc14.06-17567.24%
XOMAXOMA Corp14.95-18670.00%
REGNRegeneron Pharmaceuticals Inc14.98-18713.49%
PBYIPuma Biotechnology Inc15.05-18800.71%
EXELExelixis Inc15.79-19725.67%
NAGENiagen Bioscience Inc16.35-20421.62%
CPRXCatalyst Pharmaceuticals Inc17.34-21651.49%
MDXGMimedx Group Inc17.38-21689.51%
ARGXArgen X SE23.07-28767.31%
HALOHalozyme Therapeutics Inc23.20-28927.60%
XOMAOXOMA Corp25.34-31591.87%
VRTXVertex Pharmaceuticals Inc25.66-31978.30%
XOMAPXOMA Corp25.67-31996.07%
CTMXCytomX Therapeutics Inc25.70-32030.62%
ASNDAscendis Pharma A/S26.35-32845.98%
RPRXRoyalty Pharma plc - Class A27.50-34264.09%
SLNOSoleno Therapeutics Inc29.02-36152.64%
LGNDLigand Pharmaceuticals Inc - Class B30.19-37607.91%
BMRNBiomarin Pharmaceutical Inc37.51-46704.23%
APLSApellis Pharmaceuticals Inc39.02-48585.33%
KRYSKrystal Biotech Inc39.70-49425.78%
GMABGenmab40.20-50054.51%
ONCBeiGene Ltd67.03-83383.62%
TECHBio-Techne Corp68.59-85332.06%
VCELVericel Corp80.63-100285.00%
PHARPharming Group N.V.87.74-109120.63%
ALNYAlnylam Pharmaceuticals Inc124.93-155335.07%
TLXTelix Pharmaceuticals Ltd139.89-173919.73%
CORTCorcept Therapeutics Inc158.39-196905.00%